MindMed to Present at Upcoming May Medical Conferences
Mind Medicine Inc Ordinary Shares MNMD
News
-
MindMed to Present at Upcoming April Medical Conferences
MindMed Announces Voluntary Delisting from Cboe Canada
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
Thinking about buying stock in Entera Bio, Ocugen, Mind Medicine, MicroAlgo, or Flora Growth?
Thinking about buying stock in MicroCloud Hologram, Akebia Therapeutics, Mind Medicine, Treasure Global, or Getty Images?
Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia?
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
MindMed's stock soars 51.5% after FDA grants breakthrough designation to LSD therapy for a form of anxiety
Thinking about trading options or stock in Tesla, Meta Platforms, Intuitive Surgical, Bristol-Myers Squibb, or Mind Medicine?
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
Thinking about buying stock in Minim, GameSquare, Laser Photonics, Geron, or Mind Medicine?
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
MindMed Reports 2023 Financial Results and Business Updates
MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
Why one backer of MDMA therapy sees 'exponential' growth following FDA approval this year